Thromb Haemost 1985; 54(02): 463-465
DOI: 10.1055/s-0038-1657873
Original Article
Schattauer GmbH Stuttgart

Reactivity of Small Molecular Forms of Human Factor VIII/von Willebrand Factor with Botrocetin and Anti-Factor VIII-Coated Latex Particles

M Furlan
The Central Hematology Laboratory, Inselspital, Berne, Switzerland
,
B A Perret
The Central Hematology Laboratory, Inselspital, Berne, Switzerland
,
E A Beck
The Central Hematology Laboratory, Inselspital, Berne, Switzerland
› Author Affiliations
Further Information

Publication History

Received 29 June 1984

Accepted 14 May 1985

Publication Date:
18 July 2018 (online)

Preview

Summary

Two recently developed tests for measurement of factor VIII/von Willebrand factor (FVIII/vWF), i.e. platetelet agglutination by botrocetin and a kinetic latex antigen assay, were compared with ristocetin cofactor and electroimmunoassay, in respect with FVIII/vWF size-distribution. FVIII/vWF was measured in six cases of atypical von Willebrand’s disease (type II), in gel-filtered fractions of normal cryoprecipitate and in the course of depolymerization of purified normal FVIII/vWF by disulfide reduction. Small molecular forms of FVIII/vWF from normal and variant type II plasma, and those derived by disulfide reduction of high-molecular weight FVIII/vWF, showed remarkably decreased reactivity in ristocetin-, botrocetin- and latex-assay. We conclude that for botrocetin-induced platelet agglutination, as well as for agglutination of antibody-coated latex particles, multiple interactions with repeating subunits of FVIII/vWF are required. As a practical consequence, the combined measurement of FVIII/vWF by the latex test and electroimmunoassay provides a simple tool for discriminating between the classical von Willebrand’s disease and its variants.